Vofopitant has been used in trials studying the treatment of PTSD, Primary Insomnia, and Sleep Initiation and Maintenance Disorders. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin. Other names for this substance include Vofopitantum. Its PubChem CID is 6918331.
Vofopitant
| CAS No | 168266-90-8 |
|---|---|
| Molecular Formula | C21H23F3N6O |
| Molecular Weight | 432.4 g/mol |
| Synonyms | (2S,3S)-N-[[2-methoxy-5-[5-(trifluoromethyl)tetrazol-1-yl]phenyl]methyl]-2-phenylpiperidin-3-amine |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Vofopitant has been used in trials studying the treatment of PTSD, Primary Insomnia, and Sleep Initiation and Maintenance Disorders. The directory classifies it as a discontinued API with a synthetic source/manufacturing origin.
The listed CAS number is 168266-90-8.
The listed molecular formula is C21H23F3N6O.
The listed molecular weight is 432.4 g/mol.
(2S,3S)-N-[[2-methoxy-5-[5-(trifluoromethyl)tetrazol-1-yl]phenyl]methyl]-2-phenylpiperidin-3-amine.
The source lists Vofopitantum.